This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Sk Biopharmaceuticals Co., Ltd.. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Mo Ses Jeong: Innovator in Pharmaceutical Chemistry
Introduction
Mo Ses Jeong is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on methylcyclohexane derivatives. His research focuses on developing effective solutions for pain management.
Latest Patents
Mo Ses Jeong holds a patent for "Methylcyclohexane derivatives and uses thereof." This novel methylcyclohexane derivative is part of a pharmaceutical composition that is effective for the prevention or treatment of pain. His work in this area showcases his commitment to advancing medical science and improving patient care.
Career Highlights
Jeong is currently employed at SK Biopharmaceuticals Co., Ltd., where he continues to push the boundaries of pharmaceutical research. His dedication to innovation has positioned him as a key figure in the development of new therapeutic agents.
Collaborations
Throughout his career, Mo Ses Jeong has collaborated with talented colleagues, including Sung Jin Bae and Han Ju Yi. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Mo Ses Jeong's contributions to pharmaceutical chemistry, particularly through his patented work on methylcyclohexane derivatives, highlight his role as an influential inventor in the field. His ongoing efforts at SK Biopharmaceuticals Co., Ltd. continue to pave the way for advancements in pain management therapies.